Rare
lephants
Screener
Toggle theme
S
China SXT Pharmaceuticals, Inc.
SXTC
·
Healthcare, Drug Manufacturers - General
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2022
FY2020
FY2019
FY2018
FY2017
Total Cash from Operations:
$1.2M
Line Item
Value
% of Total
Capital Expenditures
$179.2K
15.1%
Other Investing
$7.1K
0.6%
Other Financing
$50.6K
4.3%
Working Capital
$892.1K
75.3%
Other
$2.0K
0.2%
Net Cash Flow
$54.1K
4.6%
Download CSV